Cover Image
市場調查報告書

神經調節的全球市場

Global Neuromodulation Market 2020

出版商 RNCOS E-Services Pvt. Ltd. 商品編碼 344997
出版日期 內容資訊 英文 60 Pages
訂單完成後即時交付
價格
Back to Top
神經調節的全球市場 Global Neuromodulation Market 2020
出版日期: 2015年11月01日 內容資訊: 英文 60 Pages
簡介

2020年的全球神經調節市場規模預計將達到65億美元。所謂神經調節是給予標的神經電力信號,以直接影響人體機制的治療方法,成為為各種藥物副作用所苦的人們一個好的減輕痛苦手段。神經調節有體內神經調節·體外神經調節2種技術,前者可更進一步細分為脊椎刺激·腦深部刺激·薦椎神經刺激·迷走神經刺激等。全球神經調節產業現在正在革命性變化中,預測不久的將來將取代神經疾病的傳統治療方法。

本報告提供全球神經調節 (神經調節療法) 市場相關分析,提供您治療方法概要,及主要推動及阻礙市場要素,整體市場趨勢預測,各治療法·各地區的詳細趨勢,接受力等相關之調查與考察。

第1章 分析師的見解

第2章 分析方法

第3章 神經調節:概要

第4章 推動及阻礙市場要素

  • 推動市場要素
    • 醫療費用支出的擴大
    • 老年人口的增加
    • 神經疾病患者的戲劇性增加
    • 神經調節療法的利用擴大
  • 課題
    • 醫療費給付額的減少
    • 醫院的預算額的削減
    • 地方醫院就醫受限
    • 缺乏熟練的專家

第5章 神經調節市場概要

第6章 市場區隔

  • 各技術
    • 體內神經調節
    • 體內神經調節:各用途
      • 脊椎刺激
      • 腦深部刺激
      • 薦椎神經刺激
      • 迷走神經刺激
    • 體外神經調節
  • 各地區
    • 美國
    • 歐洲
    • 亞太地區
    • 其他的國家 (RoW)

第7章 趨勢與發展

  • 新加入企業推出新產品,促使市場革命性變化
  • 改善慢性疼痛治療用神經調節
  • 透過股權·融資 (Equity Financing) ,支援神經調節市場上的技術開發活動

第8章 企業合併·收購 (M&A)

第9章 市場競爭力的評估

  • Medtronic
  • Boston Scientific
  • St. Jude Medical
  • Cyberonics

第10章 建議

圖表一覽

目錄

According to the new report by RNCOS entitled, “Global Neuromodulation Market 2020,” the Neuromodulation/Neurostimulation industry is set to revolutionize the healthcare domain and to reach US$ 6.5 Billion by 2020. Neuromodulation directly influences the body's regulation systems by applying electrical signals to target nerves. The therapy provides relief to patients from pain and accompanying side-effects of drugs. The technology used is expected to replace conventional treatments for neurological disorders in the near future.

Furthermore, RNCOS report covers an exhaustive research into different types of Neuromodulation procedures and their applications. Thereafter, based on the type of procedure, the market is segmented into internal and external neurostimulation. In terms of applications, the industry is bifurcated primarily into sacral nerve stimulation, deep brain stimulation and vague nerve stimulation, among others. Geographically, North America dominated the industry covering 41% of the global market last year.

Also, rising incidences of Alzheimer's and Parkinson syndromes, a growing ageing population, increasing awareness, and expanding applications of neurostimulation devices are key contributors to the industry's growth. The study provides a detailed description of the market size, segmentation, mergers & acquisitions, industry developments and major hurdles facing the industry. A separate section is devoted to the competitive landscape, including key players and their past five year revenue growth. Another analysis revealed that Medtronic led the market in 2014 whereas Cyberonics witnessed the highest CAGR in the market for the last five years. Other players in the competition include Boston Scientific, Nevro, Dupoy Synthesis and other small players.

To boost the neuromodulation device industry, later part of the report stresses on recommendations proposed by RNCOS' analysts. The 63 page study will enlighten readers about the latest developments, emerging markets, and potential growth segments in the global neuromodulation industry. The study is expected to generate a deep interest within those investors who are planning to draw significant profit from this industry.

Table of Contents

1. Analyst View

2. Research Methodology

3. Neuromodulation- An Introduction

4. Drivers & Challenges

  • 4.1. Drivers
    • 4.1.1. Inclining Healthcare Expenditure
    • 4.1.2. Growing Geriatric Population
    • 4.1.3. Dramatic Increase in Neurological Disorders
    • 4.1.4. Expanding Applications of Neuromodulation Therapy
  • 4.2. Challenges
    • 4.2.1. Declining Reimbursements in Healthcare
    • 4.2.2. Slashing Hospital Budgets
    • 4.2.3. Limited Access in Rural Hospitals
    • 4.2.4. Shortage of Skilled Professionals

5. Neuromodulation Market Overview

6. Market Segmentation

  • 6.1. By Technologies
    • 6.1.1. Internal Neuromodulation
    • 6.1.2. Internal Neuromodulation Market By Applications
      • 6.1.2.1. Spinal Cord Stimulation
      • 6.1.2.2. Deep Brain Stimulation
      • 6.1.2.3. Sacral Nerve Stimulation
      • 6.1.2.4. Vagus Nerve Stimulation
    • 6.1.3. External Neuromodulation
  • 6.2. By Geography
    • 6.2.1. US
    • 6.2.2. Europe
    • 6.2.3. Asia-Pacific
    • 6.2.4. Rest of World

7. Trends & Developments

  • 7.1. Startups Set to Revolutionize Market with New Products
  • 7.2. Neuromodulation Improving Treatment for Chronic Pain
  • 7.3. Equity Financing Aiding Innovation in Neuromodulation Market

8. Mergers & Acquisitions

9. Competitive Assessment

  • 9.1. Medtronic
  • 9.2. Boston Scientific
  • 9.3. St. Jude Medical
  • 9.4. Cyberonics
  • 9.5. Nevro

10. Recommendations

List of Figures:

  • Figure 5-1: Global - Neuromodulation Market (Billion US$), 2014-2020
  • Figure 6-1: Global-Neuromodulation Market by Technologies (%), 2014
  • Figure 6-2: Global-Neuromodulation Market by Technologies (%), 2020
  • Figure 6-3: Global- Internal Neuromodulation Market (Billion US$) 2014-2020
  • Figure 6-4: Global - Internal Neuromodulation Market by Applications (%), 2014
  • Figure 6-5: Global- Internal Neuromodulation Market by Applications (%), 2020
  • Figure 6-6: Global - Spinal Cord Stimulation Market (Billion US$) 2014-2020
  • Figure 6-7: Global - Deep Brain Stimulation Market (Million US$) 2014-2020
  • Figure 6-8: Global - Sacral Nerve Stimulation Market (Million US$) 2014-2020
  • Figure 6-9: Global - Vagus Nerve Stimulation Market (Million US$) 2014-2020
  • Figure 6-10: Global - External Neuromodulation Market (Million US$) 2014-2020
  • Figure 6-11: Global - Neuromodulation Market by Geography (%), 2014
  • Figure 6-12: Global - Neuromodulation Market by Geography (%), 2020
  • Figure 6-13: US - Neuromodulation Market (Billion US$) 2014-2020
  • Figure 6-14: Europe - Neuromodulation Market (Billion US$) 2014-2020
  • Figure 6-15: Asia-Pacific - Neuromodulation Market (Million US$) 2014-2020
  • Figure 6-16: ROW - Neuromodulation Market (Million US$) 2014-2020
  • Figure 9-1: Market Share of Key Players in Global Neuromodulation Market (%), 2014
  • Figure 9-2: Medtronic Inc - Neuromodulation Revenue (Million US$) 2009 & 2014
  • Figure 9-3: Medtronic Inc - Breakup of Revenue by Geographies (%), 2014
  • Figure 9-4: Boston Scientific - Neuromodulation Revenue (Million US$) 2009 & 2014
  • Figure 9-5: Boston Scientific - Breakup of Revenue by Geographies (%), 2014
  • Figure 9-6: St Jude Medical - Neuromodulation Revenue (Million US$) 2009 & 2014
  • Figure 9-7: St Jude Medical - Breakup of Revenue by Geographies (%), 2014
  • Figure 9-8: Cyberonics - Neuromodulation Revenue (Million US$) 2009 & 2014
  • Figure 9-9: Cyberonics - Breakup of Revenue by Geographies (%), 2014

List of Tables:

  • Table 7-1: Neuromodulation Products by Startups (2013-2015)
  • Table 7-2: Equity Financing in Neuromodulation Research (2013-2015)
  • Table 9-1: Revenue of Major Players in Global Neuromodulation Market (2014)
  • Table 9-2: Medtronic Inc - Revenue by Business Segments (Million US$), 2013 & 2014
  • Table 9-3: Boston Scientific - Revenue by Business Segments (Million US$), 2013 & 2014
  • Table 9-4: St Jude Medical - Revenue by Business Segments (Million US$), 2013 & 2014
Back to Top